Women and reproductive considerations Women make up the majority of GLP-1 medication users, and a few considerations are unique to this population
Semaglutide, a GLP-1 receptor agonist used for type 2 diabetes and weight management, fundamentally changes how your body processes food and beverages through delayed gastric emptying and appetite suppression
No diabetic retinopathy at baseline: typically annual exams, with earlier follow-up if high baseline A1c, large early A1c drop, or new symptoms Mild nonproliferative diabetic retinopathy: every six to twelve months, shorter intervals if rapid glucose changes or symptoms appear Moderate nonproliferative retinopathy: every three to six months Severe nonproliferative retinopathy: every two to three months Proliferative diabetic retinopathy or prior macular edema: individualized schedule, often every two to four months when stable, more frequent when starting treatment Starting semaglutide may justify scheduling one additional exam during the first six months in higher-risk patients to catch any early worsening
Advertisement If you choose to stop taking a GLP-1, we can help you with your lifestyle changes so youre able to keep the weight off in a sustainable manner, says Dr